Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, Northern Italy, Sardinia and Sweden

被引:14
作者
Vandenbroeck, K
Hardt, C
Louage, J
Fiten, P
Jäckel, S
Ronsse, I
Epplen, JT
Grimaldi, LME
Olsson, T
Marrosu, MG
Billiau, A
Opdenakker, G
机构
[1] Univ Cagliari, Dept Neurosci, Sardinia, Italy
[2] Karolinska Hosp, Ctr Mol Med, Neuroimmunol Unit, S-10401 Stockholm, Sweden
[3] Ist Sci San Raffaele, Neuroimmunol Unit, I-20132 Milan, Italy
[4] Ruhr Univ Bochum, Dept Human Mol Genet, D-4630 Bochum, Germany
[5] Univ Hosp, Inst Human Genet, Essen, Germany
[6] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
关键词
genetics; interferon; linkage; multiple sclerosis; polymorphism;
D O I
10.1038/sj.gene.6363671
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Interferon regulatory factor-1 (IRF-1) is a transcriptional inducer of the interferon-beta (IFN-beta) gene and other interferon-stimulated genes. A GT repeat polymorphism in the 7th intron of the IRF-1 gene was used as a marker to test for association with multiple sclerosis (MS) in a case-control study including individuals from Germany, Northern Italy and Sweden. In none of these populations, did we find any significant allelic association with disease. This lack of association was confirmed by testing transmission disequilibrium of individual IRF1 alleles in a representative sample of Sardinian simplex MS families. No deviation of the expected 50% transmission rates was seen. Therefore, our work does not provide evidence in favor of IRF1 being a candidate for conferring genetic susceptibility to, or protection against, MS in Europe.
引用
收藏
页码:290 / 292
页数:3
相关论文
共 27 条
  • [1] No genetic linkage between multiple sclerosis and the interferon alpha/beta locus
    Bergkvist, M
    Martinsson, T
    Aman, P
    SandbergWollheim, M
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1996, 65 (02) : 163 - 165
  • [2] CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3
  • [3] Interleukin-12 induces expression of interferon regulatory factor-1 via signal transducer and activator of transcription-4 in human T helper type 1 cells
    Coccia, EM
    Passini, N
    Battistini, A
    Pini, C
    Sinigaglia, F
    Rogge, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) : 6698 - 6703
  • [4] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    DUQUETTE, P
    GIRARD, M
    DESPAULT, L
    DUBOIS, R
    KNOBLER, RL
    LUBLIN, FD
    KELLEY, L
    FRANCIS, GS
    LAPIERRE, Y
    ANTEL, J
    FREEDMAN, M
    HUM, S
    GREENSTEIN, JI
    MISHRA, B
    MULDOON, J
    WHITAKER, JN
    EVANS, BK
    LAYTON, B
    SIBLEY, WA
    LAGUNA, J
    KRIKAWA, J
    PATY, DW
    OGER, JJ
    KASTRUKOFF, LF
    MOORE, GRW
    HASHIMOTO, SA
    MORRISON, W
    NELSON, J
    GOODIN, DS
    MASSA, SM
    GUTTERIDGE, E
    ARNASON, BGW
    NORONHA, A
    REDER, AT
    MARTIA, R
    EBERS, GC
    RICE, GPA
    LESAUX, J
    JOHNSON, KP
    PANITCH, HS
    BEVER, CT
    CONWAY, K
    WALLENBERG, JC
    BEDELL, L
    VANDENNOORT, S
    WEINSHENKER, B
    WEISS, W
    REINGOLD, S
    PACHNER, A
    TAYLOR, W
    [J]. NEUROLOGY, 1993, 43 (04) : 655 - 661
  • [5] Genetic predisposition to multiple sclerosis as revealed by immunoprinting
    Epplen, C
    Jackel, S
    Santos, EJM
    DSouza, M
    Poehlau, D
    Dotzauer, B
    Sindern, E
    Haupts, M
    Rude, KP
    Weber, F
    Stover, J
    Poser, S
    Gehler, W
    Malin, JP
    Przuntek, H
    Epplen, JT
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (03) : 341 - 352
  • [6] Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development
    Fiten, P
    Vandenbroeck, K
    Dubois, B
    Van Coillie, E
    Nelissen, I
    Van Damme, J
    Ligers, A
    Hillert, J
    Andersson, M
    Olsson, T
    Opdenakker, G
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1999, 95 (1-2) : 195 - 201
  • [7] INDUCTION OF THE TRANSCRIPTION FACTOR IRF-1 AND INTERFERON-BETA MESSENGER-RNAS BY CYTOKINES AND ACTIVATORS OF 2ND-MESSENGER PATHWAYS
    FUJITA, T
    REIS, LFL
    WATANABE, N
    KIMURA, Y
    TANIGUCHI, T
    VILCEK, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) : 9936 - 9940
  • [8] INDUCTION OF ENDOGENOUS IFN-ALPHA AND IFN-BETA GENES BY A REGULATORY TRANSCRIPTION FACTOR, IRF-1
    FUJITA, T
    KIMURA, Y
    MIYAMOTO, M
    BARSOUMIAN, EL
    TANIGUCHI, T
    [J]. NATURE, 1989, 337 (6204) : 270 - 272
  • [9] Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis in Europe: Effect of population structure on association with disease
    Goris, A
    Epplen, C
    Fiten, P
    Andersson, M
    Murru, R
    Sciacca, FL
    Ronsse, I
    Jackel, S
    Epplen, JT
    Marrosu, MG
    Olsson, T
    Grimaldi, LME
    Opdenakker, G
    Billiau, A
    Vandenbroeck, K
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (09) : 1037 - 1046
  • [10] A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex
    Haines, JL
    TerMinassian, M
    Bazyk, A
    Gusella, JF
    Kim, DJ
    Terwedow, H
    PericakVance, MA
    Rimmler, JB
    Haynes, CS
    Roses, AD
    Lee, A
    Shaner, B
    Menold, M
    Seboun, E
    Fitoussi, RP
    Gartioux, C
    Reyes, C
    Ribierre, F
    Gyapay, G
    Weissenbach, J
    Hauser, SL
    Goodkin, DE
    Lincoln, R
    Usuku, K
    GarciaMerino, A
    Gatto, N
    Young, S
    Oksenberg, JR
    [J]. NATURE GENETICS, 1996, 13 (04) : 469 - 471